FOX RUN MANAGEMENT, L.L.C. URGN UROGEN PHARMA LTD

Ownership history in FOX RUN MANAGEMENT, L.L.C.  ·  4 quarters on record

AI Ownership Summary

FOX RUN MANAGEMENT, L.L.C. reported UROGEN PHARMA LTD (URGN) in 4 quarterly 13F filings from 2025 Q1 through 2026 Q2. Peak portfolio weight reached 0.08% in 2026 Q1. The latest visible filing shows URGN at 0.05% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this URGN ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was FOX RUN MANAGEMENT, L.L.C.'s position in UROGEN PHARMA LTD, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

URGN was reported at 0.05% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.08% in 2026 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2025 Q1 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How FOX RUN MANAGEMENT, L.L.C. held URGN — position size vs. price
% of Fund (quarterly)    URGN price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 4 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 REDUCED 7,957 -17,714 -69.0% 0.05% $293K 2026-08-04 $39.92
2026 Q1 ADDED 25,671 +8,769 +51.9% 0.08% $436K 2026-05-12 $29.80
2025 Q3 REDUCED 53.4% +16.9% 16,902 -19,369 -53.4% 0.05% $337K 2025-11-12 $25.14
2025 Q1 INITIATED 36,271 0.06% $401K 2025-05-13 $10.14

FAQ About FOX RUN MANAGEMENT, L.L.C. and URGN

These are the practical questions this page is built to answer before you even open the full history table.

How long has FOX RUN MANAGEMENT, L.L.C. reported owning URGN?

FOX RUN MANAGEMENT, L.L.C. reported URGN across 4 quarterly 13F filings, from 2025 Q1 through 2026 Q2.

What was the largest reported URGN position in FOX RUN MANAGEMENT, L.L.C.'s portfolio?

The largest reported portfolio weight for URGN was 0.08% in 2026 Q1.

What is the latest reported URGN position on this page?

The most recent filing on this page is 2026 Q2, when FOX RUN MANAGEMENT, L.L.C. reported 7,957 shares, equal to 0.05% of portfolio, with an estimated market value of $293K.

What does the chart on this URGN ownership page compare?

The chart compares FOX RUN MANAGEMENT, L.L.C.'s quarterly URGN portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did FOX RUN MANAGEMENT, L.L.C. time their URGN position?

Based on 13F filing dates vs. subsequent URGN price moves, FOX RUN MANAGEMENT, L.L.C. correctly timed 2 out of 3 reported position changes (67%). The annualised alpha on URGN relative to SPY over the holding period was +141.8%.

← Back to FOX RUN MANAGEMENT, L.L.C. Holdings